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ABSTRACT  28 
Aims: To characterize postprandial glucose flux after exercise in the fed versus 29 
overnight fasted-state and to investigate potential underlying mechanisms. 30 
Methods: In a randomized order, twelve men underwent breakfast-rest (BR; 3 h 31 
semi-recumbent), breakfast-exercise (BE; 2 h semi-recumbent before 60-min of 32 
cycling (50% peak power output) and overnight fasted-exercise (FE; as per BE 33 
omitting breakfast) trials. An oral glucose tolerance test (OGTT) was completed 34 
post-exercise (post-rest on BR). Dual stable isotope tracers ([U-13C] glucose 35 
ingestion and [6,6-2H2] glucose infusion) and muscle biopsies were combined to 36 
assess postprandial plasma glucose kinetics and intramuscular signaling, 37 
respectively. Plasma intestinal fatty acid binding (I-FABP) concentrations were 38 
determined as a marker of intestinal damage. Results: Breakfast before 39 
exercise increased post-exercise plasma glucose disposal rates during the 40 
OGTT, from 44 g·120 min-1 in FE [35 to 53 g·120 min-1] (mean [normalized 95% 41 
CI]) to 73 g·120 min-1 in BE [55 to 90 g·120 min-1; p = 0.01]. This higher plasma 42 
glucose disposal rate was, however, offset by increased plasma glucose 43 
appearance rates (principally OGTT-derived), resulting in a glycemic response 44 
that did not differ between BE and FE (p = 0.11). Plasma I-FABP concentrations 45 
during exercise were 264 pg·mL-1 [196 to 332 pg·mL-1] lower in BE versus FE 46 
(p = 0.01).  Conclusion: Breakfast before exercise increases post-exercise 47 
postprandial plasma glucose disposal, which is offset (primarily) by increased 48 
appearance rates of orally-ingested glucose. Therefore, metabolic responses to 49 
fed-state exercise cannot be readily inferred from studies conducted in a fasted 50 
state. 51 
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INTRODUCTION 53 
Postprandial glycemia is a strong predictor of future mortality and morbidity. 54 
Even in people without diabetes, those with greater blood glucose excursions 55 
after feeding are at an increased risk of cardiovascular disease (47, 48). This 56 
glycemic response to food ingestion is dictated by blood glucose kinetics (i.e. 57 
the balance between the rates of glucose appearance into blood and glucose 58 
disposal from blood into peripheral tissues). Exercise potently increases 59 
glucose disposal from the blood into skeletal muscle (52), and regular exercise 60 
is therefore recommended as a lifestyle strategy to improve glycemic control.  61 
 62 
Habitual responses to exercise and nutrition are however, the culmination of not 63 
only chronic adaptations, but also the acute effects of each exposure to these 64 
daily behaviors (5, 6, 22). For example, each bout of exercise potently 65 
stimulates post-exercise insulin sensitivity and muscle glucose uptake (52). 66 
However, despite increases in blood glucose disposal rates, endurance-type 67 
exercise does not always reduce postprandial glucose excursions in the post-68 
exercise period (20, 54). The finding that postprandial blood glucose 69 
concentrations are not lowered post-exercise is because when exercise is 70 
performed (at least in the fasted state), the increase in postprandial blood 71 
glucose disposal after exercise can be offset - and even superseded - by 72 
increases in both endogenous and meal-derived blood glucose appearance 73 
rates (34, 54). 74 
 75 
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Whilst fasting prior to laboratory trials is common in order to control for baseline 76 
metabolic status, these conditions may preclude the application of findings to 77 
situations most representative of daily living. For example, most people living in 78 
developed countries spend the majority of a typical day in the postprandial state 79 
(13, 55). Therefore, most eating occasions and exercise sessions will take place 80 
in the context of this postprandial situation (23). It has previously been shown 81 
by others that plasma glucose fluxes during exercise (16), and by us that 82 
plasma glucose concentrations after exercise (24), are elevated by pre-exercise 83 
feeding. However, the effect of prior feeding on post-exercise plasma glucose 84 
flux has never been assessed. Therefore, there is a distinct lack of 85 
understanding regarding postprandial glucose kinetics under scenarios that are 86 
most representative of daily living, and it may not be valid to generalize existing 87 
observations of exercise in the fasted state. Moreover, an understanding of the 88 
underlying mechanisms responsible for any differences in postprandial glucose 89 
flux post-exercise, with prior feeding versus fasting, is still required. 90 
 91 
This study therefore aimed to characterize postprandial plasma glucose kinetics 92 
after: 1) breakfast and rest; 2) breakfast and exercise and 3) overnight fasted-93 
state exercise, while also exploring potential mechanisms (intramuscular 94 
signaling and markers of intestinal damage) to explain any differences in 95 
glucose flux between these conditions.   96 
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MATERIALS AND METHODS 97 
Ethical Approval 98 
All trials were undertaken at the University of Bath (Bath, UK) in accordance 99 
with the Declaration of Helsinki. The study was approved by the National Health 100 
Service South-West Research Ethics Committee (reference: 15/SW/0006) and 101 
registered at clinicaltrials.gov as NCT02258399. Written, informed consent was 102 
obtained from all participants prior to their participation. 103 
 104 
Study Design 105 
This study was a randomized cross-over design (randomization performed by 106 
JTG with Research Randomizer version 3.0, http://www.randomizer.org/). 107 
Preliminary testing was followed by three trials (separated by > 7 d), namely, 108 
breakfast-rest (BR), breakfast-exercise (BE) and overnight fasted-exercise (FE). 109 
A schematic for the study protocol is shown in Figure 1. For all trials 110 
participants arrived at the laboratory after a 12 to 14-h overnight fast. In BR, a 111 
porridge breakfast was consumed, followed by 3 h of rest, and then a 2-h oral 112 
glucose tolerance test (OGTT). In BE, the same breakfast was consumed, 113 
before 2 h rest and 60 min of cycling, prior to the OGTT. In FE, breakfast was 114 
omitted but the trial otherwise replicated BE. By necessity of design (food 115 
intake/exercise) the intervention was open label. Within-lab testing conditions 116 
were not different across the trials ([mean ± SD] ambient temperature [23.7 ± 117 
0.5 °C on BR, 23.7 ± 0.6 °C on BE, 23.6 ± 0.7 °C on FE) and barometric 118 
pressure [734 ± 5 mmHg on BR, 736 ± 6 mmHg on BE, 736 ± 5 mmHg on FE]; 119 
all p > 0.05).  120 
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 121 
 122 
Participants 123 
Twelve healthy and physically active men (self-reported as regular exercisers 124 
engaging in at least 30 min of exercise a minimum of 3 times per week) were 125 
recruited from Bath and North East Somerset, between May and November 126 
2015. Participant characteristics are shown in Table 1. Exclusion criteria 127 
included any history of metabolic disease, or condition that may have posed 128 
undue personal risk to the participant or introduced bias to the study.  129 
 130 
Preliminary Testing 131 
Figure 1. Protocol schematic. An oral glucose tolerance test was conducted after 
breakfast followed by rest (BR), breakfast followed by exercise (BE), or extended 
overnight fasting followed by exercise (FE). Dual stable isotope tracers ([U-13C] 
glucose ingestion and [6,6-2H2] glucose infusion) and muscle biopsies were combined 
to assess postprandial plasma glucose kinetics and intramuscular signaling, 
respectively. 
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Participants were asked to refrain from strenuous physical activity for 24 h prior 132 
to preliminary testing, but were asked to otherwise maintain their normal 133 
physical activity behaviors. They abstained from alcoholic and caffeinated 134 
drinks for 24 h prior to this visit. Food intake ceased at 8 pm on the evening 135 
before testing and participants fasted overnight (minimum 12 h), consuming 136 
only water (ad libitum) during this period. In addition, they were asked to 137 
consume 568 mL of water at least 1 h prior to testing, and to void immediately 138 
prior to arriving at the laboratory. Upon arrival, the participant’s stature was 139 
measured (Frankfurt plane) to the nearest 0.1 cm using a stadiometer (Seca 140 
Ltd, Birmingham, UK). Body mass was recorded to the nearest 0.1 kg (only light 141 
clothing permitted) using electronic weighing scales (BC543 Monitor, Tanita, 142 
Tokyo, Japan). A whole-body dual energy x-ray absorptiometry scan was 143 
completed to quantify fat and fat-free mass (DEXA; Discovery, Hologic, 144 
Bedford, UK).  145 
 146 
Participants then performed an incremental cycling exercise test at a self-147 
selected cadence on an electronically-braked ergometer (Excalibur Sport, Lode 148 
Lode Groningen, Netherlands). They were permitted to adjust the saddle and 149 
handlebar heights to their preferred position, which were replicated for cycling 150 
during the exercise trials. The initial exercise intensity was 50 W and this was 151 
increased by 50 W every four min, for four stages.  Thereafter, the intensity was 152 
increased by 20 W every min until volitional exhaustion. Heart rate (Polar 153 
Electro Oy, Kempele, Finland) and continuous breath-by-breath measurements 154 
were recorded throughout (TrueOne2400, ParvoMedics, Sandy, USA). Volume 155 
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and gas analyzers were calibrated with a 3 L calibration syringe (Hans Rudolph, 156 
Kansas City, USA) and a calibration gas (balance nitrogen mix; 16.04% O2, 157 
5.06% CO2; BOC Industrial Gases, Linde AG, Munich, Germany), respectively. 158 
Peak power output (PPO) was calculated as the work rate of the last completed 159 
stage, plus the fraction of time spent in the final non-completed stage, multiplied 160 
by the work rate increment. Peak oxygen uptake (V̇O2 peak) was calculated as 161 
the highest average V̇O2 over a rolling 30-s period.  162 
 163 
Main Trials  164 
Participants refrained from strenuous physical activity, alcohol and caffeine for 165 
24 h before all trials. They recorded the composition of their evening meal on 166 
the day before the first main trial and replicated this meal for subsequent trials, 167 
in accordance with procedures for standardizing postprandial glucose tolerance 168 
testing (10). This pre-trial standardisation protocol has been previously shown 169 
to be effective at producing overnight-fasted muscle glycogen concentrations, 170 
liver glycogen concentrations and intramyocellular lipid that are standardised 171 
across multiple trial days, in a similar population (21). To help ensure physical 172 
activity standardization, participants completed a physical activity diary and 173 
wore a physical activity monitor (ActiheartTM; Cambridge Neurotechnology, 174 
Papworth, UK) for 24 h before all trials (pre-trial 24-h physical activity energy 175 
expenditure [(mean ± standard deviation) 988 ± 500 kcal on BR, 1022 ± 521 176 
kcal on BE, 992 ± 313 kcal on FE; all p > 0.05; n = 9]. 177 
 178 
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Participants arrived at the laboratory at 0800 ± 1 h following a 12 to 14-h 179 
overnight fast and this arrival time was replicated for the subsequent trials. They 180 
were asked to void and all further urine samples were collected for the 181 
remainder of the trial to allow for urinary nitrogen excretion to be estimated from 182 
urine urea concentrations. Participants then placed their dominant hand into a 183 
heated-air box (Mass Spectrometry Facility; The University of Vermont & 184 
University of Vermont Medical Center, Burlington, USA) set to 55 °C. After 20 185 
min of rest, an intravenous catheter (BD Venflon Pro, BD, Helsingborg, 186 
Sweden) was fitted into a heated dorsal hand vein (retrograde) and a 10-mL 187 
baseline blood sample was drawn, before a 5-min expired gas sample was 188 
collected. On the first main trial for each participant (see Figure 1), a baseline 189 
muscle sample was taken from the vastus lateralis to allow for an assessment 190 
of the pathways involved in exercise and insulin signaling in muscle [5' AMP-191 
activated protein kinase (AMPK), acetyl-CoA carboxylase (ACC), protein kinase 192 
B (herein refered to as Akt2), and Akt substrate of 160 kDa (AS160).   193 
 194 
In BE and BR, a porridge breakfast was then consumed within 10 min (3 h pre-195 
OGTT) and in FE participants were allowed water only. The breakfast was 72 g 196 
of instant refined oats (Oatso Simple Golden Syrup, Quaker Oats) and 360 mL 197 
of semi-skimmed milk (Tesco), providing 431 kcal of energy ([1803 kJ]; 65 g 198 
CHO, 11 g FAT, 19 g PRO). The breakfast was high-carbohydrate (57% of 199 
energy intake) and high glycemic-index [oatmeal, made from mix (Quaker Oats) 200 
has a glycemic index of 69 (17)], as is commonly consumed in developed 201 
countries. Due to the co-ingestion of milk, this breakfast would produce a high 202 
Page 12 
insulinemic response (38, 46).  Breakfast consumption (or omission on FE) was 203 
followed by 2 h of rest, where participants remained in a semi-recumbent 204 
position, completing resting activities (e.g. watching television), with expired gas 205 
samples collected every 60 min. After 1 h 40 min of rest, (1 h 20 min pre-OGTT) 206 
a catheter was inserted into an antecubital vein (the contralateral arm to the one 207 
used for blood sampling). A primed infusion of [6,6-2H2]glucose was initiated 208 
and continued for the remaining within-lab component of the trial (Cambridge 209 
Isotope Laboratories, MA, USA; prime: 13.5 µmol.kg−1; infusion: 0.35 210 
µmol.kg−1.min−1). After 20 min (60 min pre-OGTT), and on BE and FE only, 211 
participants began 60 min of cycling at 50% PPO on an ergometer (Lode 212 
Corival, Lode B.V, Groningen, Netherlands). The cadence was self-selected 213 
(replicated for both exercise trials) and the power output was monitored via a 214 
computerized system. In BR, participants remained rested in the semi-215 
recumbent position during this period. Expired gas samples were collected 216 
every 15 min and blood samples were collected at 40 and 50 min of exercise 217 
(20 and 10 min pre-OGTT). Immediately post-exercise (or post-rest in BR) a 218 
muscle sample was taken from the vastus lateralis. Then a 2-h OGTT was 219 
completed, with arterialized blood sampled at 10-min intervals and expired gas 220 
sampled every 60 min. The OGTT was 73 g of glucose (81 g of dextrose 221 
monohydrate when corrected for water content; Myprotein, Northwich, UK) and 222 
2 g of [U-13C]glucose (99%; Cambridge Isotope Laboratories, MA, USA), to 223 
allow the rate of appearance of the orally ingested glucose (RaOGTT) to be 224 
assessed. A final muscle sample was taken post-OGTT (OGTT 120 min).  225 
 226 
Page 13 
Tracer approach, blood sampling and analysis 227 
A dual-tracer approach was employed, where the tracer infusion rate was 228 
doubled during exercise (on BE and FE) to account for an expected increase in 229 
endogenous glucose production (1) and reduced to 80% of baseline at OGTT 230 
20 min (all trials) to account for an expected suppression of endogenous 231 
glucose production after oral glucose ingestion (9). This approach reduces 232 
changes in the tracer-to-tracee ratio, thereby permitting more accurate 233 
estimations of glucose kinetics(4). Arterialized blood was sampled from a 234 
heated dorsal hand vein at baseline, at 60-min intervals during the initial 2-h 235 
rest period, at 40 and 50 min of the exercise period (or post-rest in BR) and at 236 
10-min intervals during the OGTT. Whole blood was dispensed into 237 
ethylenediaminetetraacetic acid-coated tubes (BD, Oxford, UK) which were first 238 
centrifuged (4 °C and 3500 g) for 10-min (Heraeus Biofuge Primo R, Kendro 239 
Laboratory Products Plc., UK) to obtain plasma. The plasma was then 240 
dispensed into 0.5 mL aliquots and immediately frozen at -20 °C, before longer-241 
term storage at -80 °C. 242 
 243 
Plasma glucose (intra-assay coefficient of variation [CV], 3.2%; inter-assay CV 244 
3.8%), lactate (intra-assay CV, 1.0%; inter-assay CV 4.8%), and triglyceride 245 
(intra-assay CV, 1.4%; inter-assay CV 4.0%) concentrations were measured 246 
using an automated analyzer (Daytona; Randox Lab, Crumlin, UK) as per the 247 
manufacturer’s instructions. Plasma insulin concentrations were measured 248 
using a commercially available ELISA kit (Mercodia AB, Uppsala, Sweden; 249 
intra-assay CV, 5.7%; inter-assay CV 9.9%). Plasma intestinal fatty acid binding 250 
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protein (I-FABP) concentrations were measured as a marker of intestinal cell 251 
damage using a commercially available ELISA kit (Hycult Biotech; intra-assay 252 
CV, 6.0%). Plasma NEFA concentrations were determined using an enzymatic 253 
colorimetric assay (WAKO Diagnostics; intra-assay CV, 8.9%; inter-assay CV 254 
10.4%). For all of these analyses, all plasma samples were analyzed in batch 255 
after all sample collection was completed, and for a given participant all 256 
samples (from the three trials) were run on the same plate. 257 
 258 
Plasma [U-13C]glucose and [2H2]glucose enrichments were determined by gas 259 
chromatography-mass spectrometry (GC-MS: GC, Agilent 6890N; MS, Agilent 260 
5973N; Agilent Technologies, Stockport, UK). Plasma glucose was extracted 261 
using methanol-chloroform and hydrochloric acid, dried under nitrogen gas, and 262 
then derivatised using the heptofluorobuyric acid method as previously 263 
described(30). The glucose derivative was acquired by selected ion monitoring 264 
at mass-to-charge ratios (m/z) 519, 521 and 525 for [12C], [6,6-2H2]- and [U-13C]-265 
glucose, respectively. Glucose enrichments of [13C] and [2H2] in plasma were 266 
determined using standard curves for [13C] and [2H2] glucose, and enrichments 267 
were expressed relative to those at 519 (M+0). The baseline sample was used 268 
for every trial to account for background isotopic plasma enrichments. To 269 
reduce any impact of analytical variability on calculations of glucose kinetics, 270 
glucose and enrichment data were curve fitted as previously described (63).  271 
 272 
Muscle sampling and analysis  273 
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Muscle samples were collected from the vastus lateralis under local anesthesia 274 
(~5 mL of 1% lidocaine, Hameln Pharmaceuticals Ltd., Brockworth, UK). 275 
Samples were taken from a 3-5-mm incision at the anterior aspect of the thigh 276 
with a 5-mm Bergstrom biopsy needle technique adapted for suction(57). 277 
Samples were immediately extracted from the needle and frozen in liquid 278 
nitrogen, before longer-term storage at -80 °C. The order of dominant or non-279 
dominant leg was counterbalanced across trials for the OGTT 0 min and the 280 
120 min samples. Samples were taken from separate skin incision sites, with 281 
these > 2 cm proximal to any previous incision on the same leg (59). For the 282 
OGTT 0 min sample (post exercise [or post-rest in BR]) the incision was made 283 
prior to cycling (BE and FE) and closed with Steristrips, to allow for an 284 
immediate sample to be taken post-exercise. 285 
 286 
Frozen wet tissue (20-30 mg) was freeze-dried, powdered, and dissected free 287 
of visible blood and connective tissue and added to ice cold lysis buffer [50 mM 288 
Tris (pH 7.4), 150 mM NaCl, 0.5% Sodium deoxycholate; 0.1% SDS and 0.1% 289 
NP-40] with a protease (Thermo Scientific) and phosphatase inhibitor cocktail 290 
(Millipore). Samples were homogenized with a dounce homogenizer (~ 40 291 
passes), incubated for 60 min at 4 °C with rotation, and centrifuged for 10 min 292 
(4 °C and 20,000 g). The protein content of the resultant supernatant was 293 
measured via a bicinchoninic acid (BCA) protein assay kit (Thermo Scientific). 294 
For Western blots, an equal amount of protein (40 µg) was loaded per lane for 295 
each sample and separated using sodium dodecyl sulfate polyacrylamide gel 296 
electrophoresis (SDS-PAGE) on Tris-glycine SDS–polyacrylamide gels (7% for 297 
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p-AMPKThr172, total AMPK, p-ACCSer79 and total ACC, 10% for p-AktSer473 and 298 
total Akt2 and 8% for p-AktThr308, p-AS160Thr642 and total AS160). Gels were 299 
electro-blotted using a semi-dry transfer onto a nitrocellulose membrane. 300 
Membranes were washed in Tris-buffered saline (0.09% NaCl, 100 mM Tris–301 
HCl pH 7.4) with 0.1% Tween 20 (TBS-T) and incubated for 30-min in a 302 
blocking solution (5% non-fat dry milk in TBS-T; Marvel, Premier International 303 
Foods Ltd, UK). The membranes were incubated overnight at 4 °C with primary 304 
antibodies against p-AMPKThr172, p-ACCSer79, p-AktSer473, p-AktThr308 and p-305 
AS160Thr642 (Cell Signaling Technologies, USA). In the morning, membranes 306 
were washed in TBS-T and incubated with a 1:4000 dilution of anti-species IgG 307 
horseradish peroxidase-conjugated secondary antibodies made up in the 308 
aforementioned blocking solution. After further washes, membranes were 309 
incubated in an enhanced chemiluminescence (ECL) reagent and visualized 310 
using a chemiluminescent imager (EpiChemi II Darkroom, UVP, Upland, USA). 311 
Nitrocellulose membranes were then incubated for 30-min at 50 °C in a 312 
stripping solution [62.5 mM Tris pH 6.7, 2%SDS, 100 mM 2-mercaptoethanol], 313 
before re-blotting for total AMPK, total ACC, total Akt2 (Cell Signaling 314 
Technologies, USA) and total AS160 (Merck-Milliopore, UK). For these 315 
analyses, all samples from each participant (all three trials) were run on the 316 
same gel. Band densities were quantified using VisionWorksLS Image 317 
Acquisition and Analysis Software for Windows (UVP, Upland, USA). For all of 318 
the signalling molecules reported in this experiment a ratio of phosphorylated to 319 
total protein was calculated and the results were expressed relative to the 320 
baseline sample. 321 
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 322 
Substrate utilization 323 
Expired gas samples were collected at baseline, during the initial 2-h rest period 324 
and the OGTT at 60-min intervals (for 5 min), and at 15-min intervals (for 1 min) 325 
during the exercise period (or rest in BR). For all samples, participants were 326 
provided with the mouthpiece 1 min before gas collections for a stabilization 327 
period. Samples were collected in 200 L Douglas bags (Hans Rudolph, Kansas 328 
City, USA) through falconia tubing (Baxter, Woodhouse and Taylor Ltd, 329 
Macclesfield, UK). Concurrent measures of inspired air were made to correct for 330 
changes in ambient O2 and CO2 concentrations(7). Expired O2 and CO2 331 
concentrations were measured in a known volume of each sample, using 332 
paramagnetic and infrared transducers respectively (Mini HF 5200, Servomex 333 
Group Ltd., Crowborough, East Sussex, UK). The sensor was calibrated using 334 
concentrations of low (99.998% Nitrogen, 0% O2 and CO2) and high (balance 335 
nitrogen mix, 16.04% O2, 5.06% CO2) calibration gases (both BOC Industrial 336 
Gases, Linde AG, Munich, Germany).  Urinary nitrogen excretion was estimated 337 
from urine urea concentrations, which were measured on an automated 338 
analyzer (Daytona; Randox Lab, Crumlin, UK), to allow for protein oxidation to 339 
be accounted for in calculations of substrate utilization rates.  340 
 341 
Calculations and statistical analysis 342 
A sample size estimation was completed a priori with the total rate of plasma 343 
glucose appearance as the primary outcome measure. Rose et al. (54) reported 344 
a difference in the total plasma glucose appearance of (mean ± SD) 1600 ± 345 
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1300 µmol·kg-1 during an OGTT after rest versus after fasted exercise. Using 346 
this effect size, and an alpha level of 0.05, we calculated that 12 participants 347 
were required for an 80% probability of statistically detecting an effect in the 348 
RaTOTAL using a crossover design with three trials and a two-tailed, one-way 349 
ANOVA.   350 
 351 
The total and incremental area underneath the concentration-time curve (AUC 352 
or iAUC, respectively) for each plasma metabolites or hormones was calculated 353 
using the trapezoid rule. The AUC or iAUC for each plasma metabolite or 354 
hormone was then divided by either the duration of the total within-lab period 355 
(300-min) or the OGTT observation period (120-min), as appropriate, to provide 356 
a time-averaged value (mmol·L-1), which are used as summary measures. 357 
Plasma glucose and insulin concentrations during the OGTT were used to 358 
estimate insulin sensitivity (ISI) according to the equation of Matsuda (41): [FPG 359 
and FPI are fasting plasma glucose and insulin concentrations, and MPG and 360 
MPI are mean plasma glucose and insulin concentrations in the OGTT (41)]: 361 
 362 
ISIMATSUDA(au) =
10,000
ටFPG൫mgdL-1൯•FPI൫mIUmL-1൯•MPG൫mgdL-1൯• MPI൫mIUmL-1൯
 
 363 
Plasma glucose kinetics were determined using Radziuk’s two-compartment 364 
non-steady state model (50, 51) and SAMM II software (SAAM II v2.3, The 365 
Epilson Group, Charlottesville, VA, USA). This model reduces errors in 366 
estimations of glucose kinetics that are apparent when using Steele’s (56) one 367 
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compartment model (53). The total rate of plasma glucose appearance 368 
(RaTOTAL) and glucose disappearance (Rd) were calculated as follows:   369 
 370 
Equation 1: 371 
RaTOTAL(t) =
F
E1(t)
-
V1·G(t)
E1(t)
·Ė1ሺtሻ+k12 ቌq2
iv(t)
E1(t)
-Q2ሺtሻቍ 
Equation 2: 372 
Rd (t) =RaTOTAL-V1·Ġ(t) -k21·V1·G(t) +k12·Q2ሺtሻ 
 373 
Where F is the [6,6-2H2] infusion, V1 is the glucose volume of distribution [4% of 374 
body mass (kg)], E1(t) the [2H2] plasma glucose enrichment (mole percent 375 
excess) at time t, Ė1 (t) the change in E over time [derivate of E], G(t) the 376 
plasma glucose concentrations at time t, Ġ(t) the change in G over time 377 
[derivate of G],  k12 and k21 are fixed rate constants between the peripheral and 378 
the accessible compartments (0.05 min-1 and 0.07 min-1 respectively) and q2iv 379 
and Q2 are the amounts of the tracer [2H2] and tracee in the peripheral 380 
compartment respectively, evaluated by integrating the two-compartment 381 
model.  382 
 383 
The [U-13C] enrichment of the orally ingested glucose and the RaTOTAL (from 384 
Equation 1) were used to calculate the plasma rate of appearance of glucose 385 
from the OGTT (RaOGTT). In these equations, r1 is the ratio of the infusion [2H2] 386 
and oral [U-13C] glucose tracer concentrations in plasma, ṙ (t) is the change in r 387 
over time [derivate of r], g is the [U-13C] glucose tracer in plasma, qoiv is the 388 
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amount of the [U-13C] tracer in the peripheral compartment (by integrating the 389 
two-compartment model), and EOGTT is the [U-13C] enrichment of the OGTT. 390 
 391 
Equation 3: 392 
raO(t) =RaTOTAL(t)
F
r1(t)
-
V1·g(t)
r1(t)
·ṙ1(t)+k12[ q2
iv(t)
r1(t)
-q2
0ሺtሻ] 
Equation 4: 393 
RaOGTT(t) =raO(t)[
1
EOGTT
] 
The metabolic clearance rate was calculated as the Rd divided by the plasma 394 
glucose concentrations for a given time point (G1) 395 
 396 
Equation5: 397 
Metabolic Clearance Rate = Rd(t) /G1 
Rates of whole-body fat and carbohydrate utilization were calculated using the 398 
expired gas samples and stoichiometric equations (31).  Adjustments were 399 
made to account for the contribution made by the oxidation of protein 400 
(estimated via urinary urea nitrogen). Plasma glucose utilization was assumed 401 
to be equivalent to the plasma glucose rate of disappearance (Rd) as has been 402 
confirmed previously(32). Muscle glycogen utilization during exercise (BE and 403 
FE only) was calculated as total carbohydrate utilization during exercise minus 404 
plasma glucose utilization during exercise. Due to these methods, this estimate 405 
of muscle glycogen utilization will include the utilization of other non-glucose 406 
carbohydrates (e.g. lactate). Both the production and utilization of ketone 407 
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bodies can influence the respiratory exchange ratio and therefore theoretically 408 
complicate the estimates of carbohydrate oxidation during exercise. However, 409 
during short-duration, moderate intensity exercise this effect is negligible (31). 410 
Within-lab, energy expenditure was determined assuming that lipids, glucose 411 
and glycogen give 40.81, 15.64 and 17.36 kJ·g-1 respectively (31).  412 
 413 
One-way, repeated measures ANOVA were used to assess differences 414 
between trials at baseline and for summary measures (e.g. AUCs). If multiple 415 
comparisons were necessary, two-way repeated measures ANOVAs (time x 416 
trial) was used to identify differences between trials. Degrees of freedom for F 417 
values were Greenhouse-Geisser corrected for epsilon < 0.75, with Huynh-Feldt 418 
corrections used for less severe asphericity. If time x trial interaction effects 419 
were identified, multiple paired t-tests were used to locate variance, with Holm-420 
Bonferroni step-wise adjustments to control for inflated type I errors. Pearson r 421 
and Spearman R were used to explore correlations between variables display 422 
normal and non-normal distribution, respectively. Unless otherwise stated, data 423 
in text, figures and tables are means ± 95% confidence intervals, which were 424 
normalized by removing between-subject variance (presented as 95% nCI)(39). 425 
All statistical analyses were completed using IBM SPSS statistics version 22 for 426 
windows (IBM, New York, USA), with the exception of the Holm-Bonferroni 427 
step-wise adjustments and the calculation of normalized confidence intervals 428 
which were completed using Microsoft Excel [2013]. Graph Pad Prism 7 429 
software (La Jolla, CA, USA) was used for preparation of the manuscript 430 
figures. A complete set of muscle samples was only obtained from nine 431 
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participants. Due to cannulation difficulties, for one participant’s BR trial the last 432 
blood sample obtained was at OGTT 70 min and for a different participant’s BE 433 
trial the last sample was at OGTT 60 min. For these trials (2 of 36) the group 434 
average was used for the missing data. Sensitivity analysis was completed for 435 
all measures involving blood samples and including/excluding these two 436 
participants did not influence any of the primary outcome measures. For clarity, 437 
the n is presented in all figure and table legends. 438 
  439 
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RESULTS 440 
Plasma glucose kinetics 441 
The plasma glucose disappearance rate (Rd) displayed a time x trial interaction 442 
(F = 3.123, p = 0.05), whereby plasma glucose Rd was higher during exercise 443 
versus rest (Figure 2A). Compared to extended overnight fasting, breakfast 444 
ingestion prior to exercise further increased the plasma glucose Rd during and 445 
after exercise (i.e. during the OGTT; Figure 2A). A main effect of trial was 446 
detected for the plasma glucose Rd during the OGTT (F = 7.079, p = 0.01), 447 
whereby the Rd was 45 g·120 min-1 in BR [95% nCI: 36 to 62 g·120 min-1] 448 
versus 73 g·120 min-1 in BE ([95% nCI: 55 to 90 g·120 min-1; p = 0.09 versus 449 
BR) and 44 g·120 min-1 in FE [95% nCI: 35 to 53 g·120 min-1]; p = 0.01 versus 450 
BE). Metabolic clearance rates showed a main effect of trial, with the highest 451 
rates also apparent in BE (Figure 2B; F = 7.849, p < 0.01 versus BR and FE).  452 
 453 
A main effect of trial was detected for RaTOTAL during the OGTT ([g·120 min-1]; F 454 
= 3.915, p = 0.05) which was highest in BE (Figure 2C). However, after post-455 
hoc adjustment the difference between trials was less apparent (p = 0.19 for BE 456 
versus BR and p = 0.09 for BE versus FE). A similar pattern was observed for 457 
the rate of appearance of glucose from the OGTT in plasma (RaOGTT) and a trial 458 
x time interaction was detected (Figure 2D; F = 3.134, p = 0.04). A main effect 459 
of trial was detected for the total RaOGTT (F = 5.915, p = 0.02), which was 49 460 
g·120 min-1 in BE [95% nCI: 44 to 53 g·120 min-1] (65% of the OGTT [59 to 461 
71%]) versus 42 g·120 min-1 in BR [95% nCI: 36 to 46 g·120 min-1] (56% of the 462 
OGTT [50 to 62%]; p = 0.11 versus BE) and 41 g·120 min-1 in FE [95% nCI: 35 463 
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to 47 g] (55% of the OGTT [49 to 61%] p = 0.06 versus BE). The plasma 464 
enrichment of [2H2] - and [13C]- glucose are shown in Figures 2E and 2F, 465 
respectively.  466 
 467 
Plasma glucose concentrations 468 
No difference between trials was detected for plasma glucose concentrations at 469 
baseline (Figure 3A; p > 0.05). Thereafter, a trial x time interaction was 470 
apparent (F = 2.957, p = 0.01). During the exercise period (rest in BR), plasma 471 
glucose concentrations were higher in BR versus BE at 40 min, and in BR 472 
versus FE at 50 min (both p < 0.05). At OGTT 0 min, glucose concentrations 473 
were higher in BR versus BE, and during the OGTT they were initially higher in 474 
BR versus BE and in BR versus FE (all p < 0.05), but no further differences 475 
were then detected (Figure 3A). Peak plasma glucose concentrations were 476 
higher in BR versus BE (p = 0.03), but not different in BE versus FE (Table 2; p 477 
> 0.05). A main effect of trial was detected for the within-lab (300-min) glucose 478 
AUC which was higher in BR versus BE (Table 2; p = 0.05). However, no main 479 
effect of trial was detected for the OGTT (120-min) iAUC (Figure 4A; F = 2.524, 480 
p = 0.11). 481 
  482 
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Figure 2. The plasma glucose disposal rate (Rd) (A), metabolic clearance rate  (B), the 
total rate of plasma glucose appearance (RaTOTAL) (C), the rate of appearance of glucose 
in plasma from the oral glucose tolerance test (RaOGTT) (D), and the plasma enrichments 
of [2H2]-glucose (E) and [13C]-glucose (F) before and during an oral glucose tolerance test 
that was conducted after breakfast followed by rest (BREAKFAST-REST), breakfast 
followed by exercise (BREAKFAST-EX), or extended overnight fasting followed by 
exercise (FASTED-EX). Data are means ± normalized 95% confidence intervals. n = 12 
healthy men. a = difference between breakfast rest versus breakfast exercise; b = 
breakfast rest versus fasted exercise and c = breakfast exercise versus fasted exercise 
with p < 0.05. 
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  486 
Figure 4. The time-averaged (120-min) plasma glucose (A) and plasma 
insulin (B) incremental area under the curves (iAUC) and the Matsuda 
insulin sensitivity index (C; ISIMATSUDA) for an oral glucose tolerance test 
conducted after breakfast followed by rest (BREAKFAST-REST), breakfast 
followed by exercise (BREAKFAST-EX), or extended overnight fasting 
followed by exercise (FASTED-EX). Data are means ± normalized 95% 
confidence intervals, with individual data shown as grey lines. n = 12 healthy 
men. 
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Plasma insulin concentrations 487 
At baseline, there was no difference between trials for plasma insulin 488 
concentrations (Figure 3B; p > 0.05). Main effects of time (F = 4.351, p < 0.01) 489 
and trial (F = 7.986, p < 0.01) were detected, but there was no trial x time 490 
interaction effect (F = 2.395, p = 0.07). Peak (and time to peak) plasma insulin 491 
concentrations are shown in Table 2. A main effect of trial was detected for the 492 
within-lab (300-min) insulin AUC which was higher in BR versus BE (p < 0.01), 493 
but not different in BE versus FE (Table 2; p = 0.10). A main effect of trial was 494 
apparent for the insulin OGTT iAUC [Figure 4B; (120-min) F = 5.132, p = 0.02] 495 
which was lower in BE versus BR [by 27.34 pmol·L-1 (95% nCI: 12.10 to 45.80 496 
pmol·L-1); p = 0.02] and lower in BE versus FE [by 28.67 pmol·L-1 (95% nCI: 497 
10.21 to 47.12 pmol·L-1); p = 0.04]. There was a main effect of trial for the 498 
ISIMATSUDA insulin sensitivity index (Figure 4C; F = 22.790, p < 0.01), which was 499 
higher in BE versus BR [by 8.45 au, (95% nCI: 6.42 to 10.47 au); p < 0.01] and 500 
in BE versus FE [by 6.49 au (95% nCI: 2.93 to 8.51 au); p < 0.01]. 501 
 502 
Plasma non-esterified fatty acid (NEFA) concentrations 503 
A main effect of trial (F = 4.314, p = 0.04) was detected for plasma NEFA at 504 
baseline, with concentrations of 0.30 mmol·L-1 in BR (95% nCI: 0.25 to 0.35 505 
mmol·L-1), 0.45 mmol·L-1 in BE (95% nCI: 0.36 to 0.53 mmol·L-1; p = 0.03 BE 506 
versus BR) and 0.36 mmol·L-1 in FE (95% nCI: 0.31 to 0.44 mmol·L-1; p = 0.12 507 
FE versus BR and BE). Thereafter, a time x trial interaction effect was apparent 508 
(Figure 3C; F = 11.438, p < 0.01), where plasma NEFA concentrations were 509 
lowered by breakfast consumption in BR and BE, and remained lower during 510 
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the exercise in BE versus FE, before increasing during the initial OGTT period 511 
in BE and FE versus BR. A main effect of trial was detected for the total within-512 
lab  plasma NEFA (300-min) AUC and the NEFA OGTT (120-min) AUC which 513 
in both instances was lower in BR versus BE and FE (Table 2; all p < 0.01).   514 
 515 
Other plasma metabolites  516 
No differences were detected between trials at baseline for plasma β-517 
hydroxybuturate concentrations (Figure 3D; p > 0.05). Thereafter, a time x trial 518 
interaction effect was apparent (F = 6.310, p < 0.01) where concentrations were 519 
lowered by breakfast in BR and BE. Plasma β-hydroxybuturate concentrations 520 
remained lower during exercise in BE versus FE, but increased during the 521 
OGTT with BE and FE versus BR. However, with post-hoc adjustment, the 522 
differences between trials for plasma β-hydroxybuturate concentrations became 523 
less clear (all p > 0.05). The within-lab (300-min) β-hydroxybuturate AUC was 524 
lower with BR versus BE (p = 0.03), but did not differ in BE and FE (Table 2; p 525 
= 0.35).  No baseline differences were detected for triglyceride concentrations 526 
(Figure 3E, p > 0.05) but a time x trial interaction effect was apparent (F = 527 
3.994, p < 0.01). There was an effect of trial for the within-lab (300-min) and 528 
OGTT (120-min) triglyceride AUC, which tended to be lower in FE versus BE, 529 
but with post-hoc adjustment this difference between trials was less clear 530 
(Table 2; p > 0.05). Plasma lactate concentrations at baseline were not different 531 
across trials (p > 0.05) but were lower in BR versus BE and FE in the exercise 532 
period (rest in BR) and at OGTT 0 min, but were then higher in BR versus BE 533 
during the OGTT (time x trial; F = 20.305, p < 0.01). No effect of trial was 534 
Page 30 
detected for the total within-lab (300-min) lactate AUC, but a main effect of trial 535 
was detected for the lactate OGTT (120-min) AUC, which higher in BR versus 536 
BE (Table 2; p < 0.01).  537 
 538 
Plasma intestinal fatty acid binding protein (I-FABP) concentrations 539 
There was no difference between trials at baseline for plasma I-FABP 540 
concentrations (Figure 3F; p > 0.05), but these were lower after breakfast (time 541 
x trial interaction effect; F = 6.844, p < 0.01) in BR and BE versus FE (both p < 542 
0.05). During and post-exercise (or rest in BR), I-FABP concentrations were 543 
lower in BR and BE versus FE and remained lower in BR versus FE until OGTT 544 
20 min (all p < 0.05). The within-lab (300-min) I-FABP AUC was lower in BR 545 
and BE versus FE (Table 2; p = 0.01 and p = 0.05 respectively).  546 
 547 
Activation of exercise and insulin signaling pathways in skeletal muscle 548 
Time x trial interaction effects were apparent for AMPKThr172 (ratio p-AMPK to 549 
total-AMPK) and ACCSer79 (ratio pACC to total ACC) phosphorylation, if 550 
normalized to the baseline muscle sample (Figure 5A; F = 5.154, p = 0.04 and 551 
Figure 5B, F = 5.881, p = 0.02, respectively). Compared to the breakfast-rest 552 
trial (BR), skeletal muscle AMPKThr172 phosphorylation was higher post-exercise 553 
(or post-rest in BR) in the breakfast and exercise (BE) trial [by 1.9 fold (95% 554 
nCI: 0.9 to 2.8 fold); p = 0.04] and was also higher in BE versus the fasted-555 
exercise (FE) trial [by 1.0 fold (95% nCI: 0.2 to 2.0 fold); p = 0.01]. A similar 556 
pattern was apparent for ACC phosphorylation, which was higher post-exercise 557 
(or post-rest in BR) in BE versus BR [by 6.7 fold (95% nCI: 5.4 to 8.0 fold); p = 558 
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0.03] but did not differ between BE and FE (p = 0.09). By OGTT 120 min, 559 
ACCSer79 and AMPKThr172 phosphorylation had returned to baseline levels in all 560 
three trials (all p > 0.05). No time x trial interaction (F = 2.110, p = 0.16) nor a 561 
main effect of trial (F = 0.098, p = 0.83) was detected for AktSer473 (ratio p-562 
AktSer473 to total-Akt2) phosphorylation (Figure 6A). A main effect of time (F = 563 
9.907, p = 0.01) was observed, where AktSer473 phosphorylation was elevated at 564 
OGTT 120 min in all trials. Similarly no time x trial interaction (F = 1.533, p = 565 
0.25) nor a main effect of trial (F = 0.484, p = 0.56) was detected for AktThr308 566 
(ratio p-AktThr308 to total-Akt2) phosphorylation (Figure 6B). A main effect of 567 
time (F = 10.598, p = 0.01) was also detected for this phosphorylation site, 568 
whereby AktThr308 phosphorylation was elevated at OGTT 120 min in all trials. 569 
For AS160Thr642 phosphorylation (ratio p-AS160Thr642 to total-AS160), a time x 570 
trial interaction was detected (Figure 6C; F = 4.430, p = 0.03), whereby the 571 
AS160Thr642 phosphorylation was not different between BR and BE at any time, 572 
was higher pre-OGTT in BE compared to FE (p = 0.04), but was not different 573 
between BE and FE at 120-min post-OGTT (p = 0.69).  574 
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Substrate utilization 586 
Across the duration of the trial carbohydrate utilization was higher in BE versus 587 
BR (Figure 7; by 514 kcal, [95% nCI: 452 to 576 kcal] and higher in BE versus 588 
FE (by 124 kcal, [95% nCI: 18 to 230 kcal], both p < 0.01). This difference in 589 
carbohydrate utilization between BE and FE was derived from a higher 590 
utilization of plasma glucose and other carbohydrate sources (i.e. primarily 591 
muscle glycogen, but also plasma lactate) in BE (p = 0.02 and p = 0.04 592 
respectively). Within-lab fat utilization did not differ between BR and BE (p = 593 
0.25), but was higher in FE versus BE (by 138 kcal, [95% nCI: -6 to 224 kcal], p 594 
= 0.03). Muscle glycogen utilization during exercise (g·kg body mass-1) was 595 
positively correlated (R = 0.64, p < 0.01) with skeletal muscle ACCSer79 596 
phosphorylation (ratio p-ACC to total-ACC) after exercise conducted following 597 
breakfast consumption (BE) or extended overnight fasting (FE).  598 
  599 
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DISCUSSION  602 
This is the first study to assess the effect of pre-exercise feeding on 603 
postprandial plasma glucose kinetics after exercise. Our data demonstrate that 604 
pre-exercise feeding increases plasma glucose disposal during meals 605 
consumed after exercise, despite lower insulinemia in this condition. 606 
Characterizing glucose flux at meals is important because this determines 607 
postprandial glycemia; a predictor of cardiovascular disease risk (47, 48). 608 
Previous work has only studied postprandial glucose flux after fasted-state 609 
exercise. As most people consume food and perform exercise while still in a 610 
postprandial period from a prior meal (13, 23, 55) our results describe the 611 
physiological responses to feeding that are more readily applicable to scenarios 612 
that are representative of normal daily living. Moreover, our novel data 613 
demonstrate that metabolic responses to exercise conducted in an overnight 614 
fasted state and to meals that are consumed post-exercise cannot be easily 615 
extrapolated to conditions where breakfast has been consumed. 616 
 617 
The disposal of plasma glucose (the disappearance rate) into skeletal muscle is 618 
elevated after exercise, via insulin-dependent and -independent pathways (25). 619 
We observed a higher postprandial plasma glucose disposal rate with breakfast 620 
versus fasting before exercise. The higher postprandial plasma glucose rate of 621 
disposal with pre-exercise breakfast ingestion was apparent despite lower 622 
insulinemia in the breakfast-exercise trial. At rest, breakfast consumption 623 
improves glucose tolerance and insulin sensitivity at subsequent meals [known 624 
as the “second-meal effect” (5, 20, 26)]. Mechanisms likely relate to delayed 625 
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gastric emptying (19), a potentiation of early phase insulinemia at the second 626 
meal (37) and enhanced glucose uptake into muscle due to increased GLUT4 627 
trafficking (18). Our findings show that breakfast ingestion (versus fasting) prior 628 
to exercise enhances subsequent glucose disposal at post-exercise meals in 629 
the presence of lower insulinemia, suggesting that the second-meal effect is 630 
maintained even if exercise is performed between meals. Whilst the effects of 631 
pre-exercise feeding on the metabolic responses during subsequent exercise is 632 
well characterised (15, 43), our data therefore provide new insights regarding 633 
postprandial glucose metabolism after exercise in the fed versus fasted state. 634 
 635 
Molecular insulin-signaling pathways are instrumental mediators of glucose 636 
disposal in response to exercise and/or nutrition (11). We therefore determined 637 
the activation status of key proteins involved in glucose uptake in skeletal 638 
muscle [the primary site of postprandial glucose disposal (14)]. Akt activation 639 
(Thr308 and Ser473 phosphorylation) two hours after OGTT began, was 640 
unaffected by prior exercise or prior breakfast ingestion. However, the timing of 641 
muscle sampling could be responsible for this result. It is possible that 642 
differences in Akt activation between trials may have been apparent earlier in 643 
the postprandial period, as peak Akt phosphorylation can be variable, occurring 644 
as early as 30 min after an OGTT (35). Thus, despite the lack of a measurable 645 
difference, we cannot rule out a role for insulin signaling in the glucose disposal 646 
responses we observed. Distal proteins within the insulin signalling pathway can 647 
be activated after exercise, without detectable differences in Akt 648 
phosphorylation (61). We therefore measured AS160Thr642 activation as this 649 
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phosphorylation site has been previously shown to be activated by both insulin 650 
and exercise stimulation (58). However, our data show that AS160Thr642 651 
phosphorylation was not different two hours post-OGTT with breakfast versus 652 
fasting before exercise, providing further evidence that differences in early 653 
stages of the activation of the insulin signalling pathway were not responsible 654 
for the higher plasma glucose disposal rate we observed when breakfast was 655 
ingested before exercise. 656 
 657 
AMPK activity also plays a key role in muscle glucose uptake and stimulate 658 
GLUT4 translocation (27). The greater post-exercise skeletal muscle AMPK 659 
activation with breakfast prior to exercise may have contributed to the higher 660 
glucose disposal rate in that trial. This AMPK response seems to be specific to 661 
skeletal muscle, as we have previously shown that post-exercise adipose tissue 662 
AMPK content is unaffected by pre-exercise feeding (12). The increase in 663 
skeletal muscle AMPK activity with pre-exercise feeding that we report in the 664 
present study may seem surprising given that the ingestion of large amounts (> 665 
200 g) of carbohydrate before and during exercise can blunt AMPK signaling in 666 
muscle (3, 29). This blunting is partly because low muscle glycogen 667 
concentrations stimulate AMPK activity (42). The modest amount (65 g) of 668 
carbohydrate ingested by participants in our study may explain why we did not 669 
observe an elevated AMPK response in our fasted-exercise trial. For example, 670 
when smaller carbohydrate doses are ingested before and/or during exercise (~ 671 
120 g or less) the exercise induced increase in the phosphorylation of AMPK 672 
and ACC is not always suppressed compared to when a placebo is ingested (2, 673 
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36, 58), although in one study this result was apparent despite a suppression of 674 
α2-AMPK activity when carbohydrate was ingested (2). 675 
 676 
The heightened AMPK response observed in the current study with breakfast 677 
before exercise may be explained by the type of carbohydrate ingested before 678 
exercise (high-glycemic index) in the breakfast-exercise trial, as this can 679 
stimulate muscle glycogen use during exercise, especially when no 680 
carbohydrate is ingested during the activity (62). Thus, the high-glycemic index 681 
breakfast with a modest carbohydrate content in the present study, may have 682 
stimulated muscle glycogen utilization during exercise without supplying 683 
sufficient carbohydrate to replace additional glycogen utilization, resulting in 684 
lower post-exercise muscle glycogen concentrations with breakfast versus 685 
fasting before exercise. This could explain the enhanced exercise-induced 686 
AMPK response if breakfast was consumed prior to exercise. However, we had 687 
insufficient tissue to measure muscle glycogen concentrations in all participants, 688 
and our data only provide rates of muscle glycogen utilization (which was higher 689 
with feeding versus fasting before exercise). Nevertheless, in the two 690 
participants for whom we had sufficient tissue to perform glycogen analyses, 691 
these data were in agreement with the tracer-derived calculations of muscle 692 
glycogen utilization (data not shown) and AMPK signaling assessed by western 693 
blotting. Consistent with this, the present data demonstrated that post-exercise 694 
ACCSer79 phosphorylation – as a marker of activation of the AMPK pathway - 695 
positively correlated with muscle glycogen utilization during exercise. Thus, 696 
taken together our results suggest that the increased post-exercise plasma 697 
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glucose disposal rates with pre-exercise feeding versus fasting may have been 698 
mediated through enhanced AMPK signaling, which is itself a consequence of 699 
altered fuel use during exercise. AMPK signaling and resulting muscle glycogen 700 
concentrations following exercise after breakfast should now be explored.  701 
 702 
The higher plasma glucose disposal rate (despite lower plasma insulin 703 
concentrations), that we observed in the breakfast-exercise trial, may be due to 704 
differences in GLUT4 trafficking downstream of the signalling proteins we 705 
measured. Insulin-stimulated GLUT4 translocation and insulin sensitivity of 706 
skeletal muscle are increased in vitro, if muscle is pre-treated with insulin, 707 
without differences in AktSer473 or AktThr308 activation, or the transport activity of 708 
GLUT4 (18). This suggests priming of skeletal muscle by prior insulin exposure 709 
enhances subsequent insulin action. Pre-treatment with insulin and exercise 710 
augments this response, possibly because insulin (33) and exercise (28) 711 
stimulate GLUT4 translocation from different intracellular stores (8, 49). As 712 
such, in the current work, prior breakfast and exercise (the multiple stimuli in 713 
BE), may have enhanced skeletal muscle GLUT4 translocation during the 714 
OGTT. Although technically challenging future work should now quantify GLUT4 715 
trafficking with fed versus fasted state exercise to confirm this. It is also possible 716 
that hepatic glucose disposal accounts for some of the increase in glucose 717 
disposal following BE versus FE. Similarly to skeletal muscle, insulin-stimulated 718 
hepatic glucose uptake is enhanced by prior exposure to insulin in dogs (44, 719 
45). Thus, assuming that this response persists in humans and after exercise, 720 
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priming of the liver by prior breakfast could also contribute to greater glucose 721 
disposal during meals consumed post-exercise. 722 
 723 
The increases in post-exercise glucose disposal with prior breakfast 724 
consumption were, however, offset by alterations in plasma glucose 725 
appearance. As such, postprandial glucose concentrations did not differ 726 
between the two exercise trials. Postprandial plasma glucose appearance rates 727 
are determined by three main factors: 1) the appearance of glucose from the 728 
meal; 2) residual appearance of glucose from previous meals; and/or 3) liver 729 
glucose output (glycogenolysis or gluconeogenesis). We showed that 730 
alterations in the postprandial plasma glucose appearance rate (RaTOTAL) after 731 
exercise with prior breakfast was mostly driven by increased appearance of 732 
glucose from the post-exercise OGTT. These alterations in the RaTOTAL suggest 733 
that differences in gut function (i.e. increased intestinal damage or absorptive 734 
capacity) and/or splanchnic blood flow altered the RaTOTAL. Thus, breakfast prior 735 
to exercise may alter postprandial glycemia via factors related to intestinal 736 
absorption and splanchnic handling of glucose, rather than just glucose 737 
metabolism by skeletal muscle.  738 
 739 
There are several potential mechanisms which may explain the differences in 740 
glucose appearance rates due to intestinal absorption and/or splanchnic 741 
handling of glucose. Plasma I-FABP concentrations are used as a marker of 742 
damage to intestinal epithelial cells (60). We noted lower plasma I-FABP 743 
concentrations in the breakfast-exercise versus fasted-exercise trial, despite 744 
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increased plasma glucose appearance rates of the orally-ingested glucose 745 
post-exercise. It is therefore unlikely that increased intestinal damage was 746 
responsible for the higher plasma glucose appearance rates we observed with 747 
feeding versus fasting before exercise. The better maintenance of splanchnic 748 
perfusion during exercise with prior feeding is a likely explanation for this 749 
response (15). If splanchnic perfusion was better maintained during exercise 750 
with prior feeding, this may have also directly facilitated higher OGTT-derived 751 
glucose appearance rates in that trial versus the fasted-exercise trial. It should 752 
be acknowledged however, that this intestinal damage response may be 753 
specific to cycling, and could differ with other exercise modalities (e.g. running), 754 
within the context of pre-exercise feeding. An alternative mechanism for higher 755 
appearance rate of orally-ingested glucose with feeding before exercise could 756 
also be that apical glucose transporters were primed by the prior breakfast 757 
ingestion (40). Although further underlying mechanism(s) remain unclear, and 758 
should therefore be investigated with future work, we showed that a major 759 
determinant of post-exercise glycemia (plasma glucose appearance rates) are 760 
altered by pre-exercise feeding and that this is unlikely to be explained by 761 
increases in intestinal damage.  762 
 763 
Our results show that the metabolic and intramuscular signaling responses to 764 
exercise conducted in a fed state cannot be readily inferred from responses 765 
observed with exercise in a fasted state. As well as a continual investigation of 766 
the mechanisms responsible for differences in postprandial glucose metabolism 767 
with altered pre-exercise feeding, future work should study whether the results 768 
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we observed are apparent with different post-exercise meals (including the co-769 
ingestion of fat and protein). Moreover, if the acute alterations in postprandial 770 
metabolism translate into longer-term differences in insulin sensitivity with 771 
repeated bouts of exercise in the fed versus fasted state, and in overweight and 772 
obese populations, should now be a focus for future work.  773 
 774 
To conclude, eating breakfast (versus fasting) before exercise increases post-775 
exercise plasma glucose disposal rates but this is offset by increases in 776 
appearance rates of (mainly) orally-ingested glucose, a result that does not 777 
appear to be explained by a greater intestinal damage response to the exercise. 778 
We showed that pre-exercise breakfast consumption lowers insulinema at 779 
meals that are consumed post-exercise, providing new evidence that the 780 
second meal effect is maintained even when exercise is performed between 781 
eating occasions.  782 
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TABLES  995 
 996 
 997 
Table 1. Participant Characteristics 
Age (y) 23 (3) 
Stature (cm) 179.8 (4.4) 
Body mass (kg) 76.3 (7.9) 
Body Mass Index (kg·m-2) 23.6 (2.90) 
Fat mass (kg)1 10.6 (3.7) 
Fat Mass Index (kg·m-2)1 3.26 (1.12) 
Body fat (%)1 14 (4) 
Fat free mass (kg)1 65.5 (6.4) 
V̇O2peak (L·min-1) * 4.00 (0.72) 
V̇O2peak (mL·kg·min-1) * 53 (10) 
Peak Power Output (W) 317 (67) 
HRMAX, (beats·min-1) 189 (10) 
Data are presented as means and (standard deviation). V̇O2peak = peak 
oxygen uptake. n = 12. *n = 11, due to technical difficulties with the breath-
by-breath analysis during one participant’s preliminary testing. 1 = derived 
by dual-energy x-ray absorptiometry (DEXA). 
Table 2. Peak plasma concentrations, time to peak concentrations, and the time-averaged area 
under the curve (AUC) for various metabolites and hormones measured during the total within-lab 
period (300-min) and/or during an oral glucose tolerance test observation (120-min) that was 
conducted after breakfast followed by rest (Breakfast-Rest), breakfast followed by exercise 
(Breakfast-Exercise), or extended overnight fasting followed by exercise (Fasted-Exercise). 
 Breakfast-
Rest 
Breakfast-
Exercise 
Fasted-
Exercise 
 
Peak glucose conc. (mmol·L 1) 10.62 (9.98, 11.25) 9.65 (9.27, 10.03) a 9.82 (9.44, 1 .45) F = 4.895, p = 0.03 
Time to peak glucose (min) 36 (24, 47) 49 (36, 62) 49 (36, 61) F = 2.588, p = 0.12 
Glucose AUCTOTAL (mmol·L-1) 6.41 (6.21, 6.60) 6.05 (5.90, 6.15) 
a 6.07 (5.93, 6.27) F = 6.126, p = 0.01 
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 998 
 999 
Peak insulin conc. (pmol·L-1) 286 (231, 341) 209 (148, 269) 282 (222, 337) F = 3.900, p = 0.07 
Time to peak insulin (min) 38 (26, 49) 56 (47, 65) a 43 (33, 54) F = 4.579, p = 0.03 
Insulin AUCTOTAL (pmol·L-1) 88 (79, 97) 62 (54, 71) aa 76 (67, 85) F = 9.28, p < 0.01 
NEFA AUCTOTAL(mmol·L-1) 0.16 (0.12, 0.19) 0.28 (0.24, 0.33)
aa 0.37 (0.31,0.42)bb F = 24.98, p < 0.01 
NEFA AUCOGTT (mmol·L-1) 0.10 (0.06, 0.14) 0.24 (0.20, 20.29) 
aa 0.26 (0.22, 0.31) bb F = 15.51, p < 0.01 
Triglyceride AUCTOTAL (mmol·L-1) 0.85 (0.79, 0.91) 0.81 (0.75, 0.86) 0.75 (0.70, 0.79) F = 4.319, p = 0.03 
Triglyceride AUCOGTT (mmol·L-1) 0.84 (0.77, 0.92) 0.79 (0.72, 0.86) 0.70 (0.64, 0.77) F = 4.677, p = 0.02 
Lactate AUCTOTAL (mmol·L-1) 1.05 (0.96, 1.13) 1.19 (1.08, 1.30) 1.16 (1.07, 1.27) F = 3.645, p = 0.06 
Lactate AUCOGTT (mmol·L-1) 1.12 (1.04, 1.20) 0.97 (0.89, 1.04) 
aa 1.03 (0.96, 1.11) F = 6.479, p = 0.02 
β-hydroxybuturate AUCTOTAL 
(mmol·L-1) 
0.03 (0.00, 0.06) 0.08 (0.06, 0.13) a 0.14 (0.09, 0.19) b F = 5.936, p = 0.03 
I-FABP AUCTOTAL (pg·mL-1) 279 (242, 317) 304 (267, 366) 415 (353, 476) 
b cc F = 10.87, p < 0.01 
Data are means and (normalized 95% confidence intervals). conc. = concentration; AUCTOTAL = the time-
averaged area underneath the concentration-time curve for the total within-lab period (300-min); AUCOGTT = the 
time-averaged area underneath the concentration-time curve for the oral glucose tolerance test (120-min); I-
FABP = intestinal fatty acid binding protein. n = 12 healthy men a represents a difference between breakfast 
rest and breakfast exercise, b a difference between breakfast rest and fasted exercise and c a difference 
between  breakfast exercise  and  fasted exercise with p < 0.05. aa, bb or cc is the same difference between 
trials but with p < 0.01. 
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LEGENDS TO FIGURES 1000 
Figure 1. Protocol schematic. An oral glucose tolerance test was conducted 1001 
after breakfast followed by rest (BR), breakfast followed by exercise (BE), or 1002 
extended overnight fasting followed by exercise (FE). Dual stable isotope 1003 
tracers ([U-13C] glucose ingestion and [6,6-2H2] glucose infusion) and muscle 1004 
biopsies were combined to assess postprandial plasma glucose kinetics and 1005 
intramuscular signaling, respectively. 1006 
 1007 
 1008 
Figure 2. The plasma glucose disposal rate (Rd) (A), metabolic clearance rate  1009 
(B), the total rate of plasma glucose appearance (RaTOTAL) (C), the rate of 1010 
appearance of glucose in plasma from the oral glucose tolerance test (RaOGTT) 1011 
(D), and the plasma enrichments of [2H2]-glucose (E) and [13C]-glucose (F) 1012 
before and during an oral glucose tolerance test that was conducted after 1013 
breakfast followed by rest (BREAKFAST-REST), breakfast followed by exercise 1014 
(BREAKFAST-EX), or extended overnight fasting followed by exercise 1015 
(FASTED-EX). Data are means ± normalized 95% confidence intervals. n = 12 1016 
healthy men. a = difference between breakfast rest versus breakfast exercise; b 1017 
= breakfast rest versus fasted exercise and c = breakfast exercise versus fasted 1018 
exercise with p < 0.05. 1019 
 1020 
Figure 3. Plasma glucose (A), plasma insulin (B), plasma non-esterified fatty 1021 
acids (NEFA; C), plasma β-hydroxybuturate (D) plasma triglyceride (E), and 1022 
plasma intestinal fatty acid binding protein (IFAB-P; F) concentrations before 1023 
and during an oral glucose tolerance test that was conducted after breakfast 1024 
followed by rest (BREAKFAST-REST), breakfast followed by exercise 1025 
(BREAKFAST-EX), or extended overnight fasting followed by exercise 1026 
(FASTED-EX). Data are means ± normalized 95% confidence intervals. n = 12 1027 
healthy men. a = difference between breakfast rest versus breakfast exercise; b 1028 
= breakfast rest versus fasted exercise and c = breakfast exercise versus fasted 1029 
exercise with p < 0.05. 1030 
 1031 
Figure 4. The time-averaged (120-min) plasma glucose (A) and plasma insulin 1032 
(B) incremental area under the curves (iAUC) and the Matsuda insulin 1033 
sensitivity index (C; ISIMATSUDA) for an oral glucose tolerance test conducted 1034 
after breakfast followed by rest (BREAKFAST-REST), breakfast followed by 1035 
exercise (BREAKFAST-EX), or extended overnight fasting followed by exercise 1036 
(FASTED-EX). Data are means ± normalized 95% confidence intervals, with 1037 
individual data shown as grey lines. n = 12 healthy men. 1038 
 1039 
Figure 5. The phosphorylation of 5' AMP-activated protein kinase (A; phospho 1040 
AMPKThr172, ratio p-AMPK to total-AMPK) and the phosphorylation of acetyl-1041 
CoA carboxylase (B; phospho ACCSer79, ratio p-ACC to total-ACC) before (PRE-1042 
OGTT) and after (POST-OGTT) an oral glucose tolerance test that was 1043 
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conducted after breakfast followed by rest (BREAKFAST-REST [BR]), breakfast 1044 
followed by exercise (BREAKFAST-EX [BE]), or extended overnight fasting 1045 
followed by exercise (FASTED-EX [FE]). All samples were taken from the 1046 
vastus lateralis. Samples were normalized to the baseline muscle sample for 1047 
each participant (collected in the resting fasted state on the first main trial for 1048 
each participant). Data are means ± normalized 95% confidence intervals. n = 9 1049 
healthy men. 1050 
 1051 
Figure 6. The phosphorylation of Akt2 (A; phospho AktSer473, ratio p-Akt Ser473 to 1052 
total-Akt2 and B; phosphor AktThr308, ratio p-AktThr308 to total-Akt2) and the 1053 
phosphorylation of AS160 (C; AS160Thr642, ratio p-AS160Thr642 to total-AS160) 1054 
before (PRE-OGTT) and after (POST-OGTT) an oral glucose tolerance test that 1055 
was conducted after breakfast followed by rest (BREAKFAST-REST [BR]), 1056 
breakfast followed by exercise (BREAKFAST-EX [BE]), or extended overnight 1057 
fasting followed by exercise (FASTED-EX [FE]). All samples were taken from 1058 
the vastus lateralis. Samples were normalized to the baseline muscle sample 1059 
for each participant (collected in the resting fasted state on the first main trial for 1060 
each participant). Data are means ± normalized 95% confidence intervals. n = 9 1061 
healthy men. 1062 
 1063 
Figure 7. Within-lab (300-min) substrate utilization after breakfast followed by 1064 
rest (BREAKFAST-REST), breakfast followed by exercise (BREAKFAST-EX), 1065 
or extended overnight fasting followed by exercise (FASTED-EX). Within-lab 1066 
substrate utilization was calculated assuming that the plasma glucose 1067 
disappearance rate was equivalent to plasma glucose utilization. Glycogen 1068 
utilization during exercise (on breakfast exercise and fasted exercise only) was 1069 
calculated as total carbohydrate utilization (from indirect calorimetry) minus 1070 
plasma glucose utilization during exercise. This estimate of muscle glycogen 1071 
utilization will therefore include the utilization of other non-glucose (e.g. lactate) 1072 
carbohydrates. GLU = glucose; M-GLY = muscle glycogen; PRO = protein; 1073 
CHO = carbohydrate. Data are presented as means ± 95% confidence 1074 
intervals. n = 12 healthy men.  1075 
